Related Experiment Video
Updated: May 29, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Better late than early: FDG-PET imaging in metastatic renal cell carcinoma
Michael R Harrison1, Daniel J George
1Divisions of Medical Oncology, Department of Medicine, and Urology, Duke University Medical Center, Durham, North Carolina, USA.
Abstract:
Sunitinib treatment benefits patients with metastatic renal cell carcinoma (mRCC), but response duration can vary widely and resistance is not predicted by standard measures. [¹⁸F]fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET) uptake is variable in mRCC, but changes in FDG-PET uptake may be useful in monitoring disease progression. Further work is needed to personalize treatment for patients with mRCC.
